Inovio Pharmaceuticals
INO
#9646
Rank
โ‚น10.74 B
Marketcap
โ‚น104.00
Share price
21.10%
Change (1 day)
-26.62%
Change (1 year)

Earnings for Inovio Pharmaceuticals (INO)

Earnings in 2026 (TTM): -โ‚น7.78 Billion

According to Inovio Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -โ‚น8.62 Billion, an increase over its 2024 earnings that were of -โ‚น10.22 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Inovio Pharmaceuticals from 1999 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น7.78 Billion-9.8%
2025 -โ‚น8.62 Billion-15.67%
2024 -โ‚น10.22 Billion-20.03%
2023 -โ‚น12.78 Billion-51.56%
2022 -โ‚น26.38 Billion-8.26%
2021 -โ‚น28.75 Billion95.4%
2020 -โ‚น14.72 Billion36.62%
2019 -โ‚น10.77 Billion20.19%
2018 -โ‚น8.96 Billion10.94%
2017 -โ‚น8.08 Billion9.59%
2016 -โ‚น7.37 Billion118.9%
2015 -โ‚น3.37 Billion-10.67%
2014 -โ‚น3.77 Billion83.32%
2013 -โ‚น2.06 Billion
2011 -โ‚น2.13 Billion15.64%
2010 -โ‚น1.84 Billion37.7%
2009 -โ‚น1.34 Billion2.19%
2008 -โ‚น1.31 Billion-14.09%
2007 -โ‚น1.52 Billion19.12%
2006 -โ‚น1.28 Billion9.62%
2005 -โ‚น1.17 Billion5.77%
2004 -โ‚น1.1 Billion73.08%
2003 -โ‚น0.64 Billion12.75%
2002 -โ‚น0.57 Billion
2000 -โ‚น0.86 Billion53.93%
1999 -โ‚น0.56 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น2.478 T-29,892.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น1.506 T-18,200.67%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚น1.010 T-12,245.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น1.023 T-12,402.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น1.254 T-15,182.36%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น955.23 B-11,580.81%๐Ÿ‡ฌ๐Ÿ‡ง UK
Cleveland BioLabs
CBLI
-โ‚น0.27 Billion-96.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
-โ‚น15.26 Billion 83.29%๐Ÿ‡บ๐Ÿ‡ธ USA